Jph3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
JPH3 (Junctophilin 3) is a gene that encodes a member of the junctophilin family of proteins, which are essential components of cellular junctional membrane complexes. Expansion of a CAG/CTG trinucleotide repeat in the JPH3 gene causes Huntington's disease-like 2 (HDL2), a rare autosomal dominant neurodegenerative disorder that clinically resembles Huntington's disease. [1]
| Attribute | Value | [2]
|-----------|-------| [3]
| Gene Symbol | JPH3 | [4]
| Full Name | Junctophilin 3 |
| Chromosomal Location | 16q24.3 |
| NCBI Gene ID | 57338 |
| Ensembl ID | ENSG00000125900 |
| UniProt ID | Q9Y2W5 |
| OMIM ID | 605714 |
JPH3 encodes Junctophilin-3, a membrane protein that plays critical roles in forming and maintaining junctional membrane complexes (JMCs) between the plasma membrane and the endoplasmic reticulum (ER). Key functions include:
In the brain, JPH3 is highly expressed in:
HDL2 is caused by an expanded CAG/CTG trinucleotide repeat in the JPH3 gene. The clinical presentation is remarkably similar to Huntington's disease:
The pathogenic mechanisms include:
JPH3 shows high expression in:
The high expression in striatal medium spiny neurons correlates with the selective vulnerability in HDL2.
Current therapeutic approaches for HDL2 include:
JPH3 encodes a protein of approximately 638 amino acids with the following domain organization:
| Domain | Position | Function |
|---|---|---|
| N-terminal membrane-binding domain | AA 1-270 | Binds to plasma membrane phosphoinositides |
| Central alpha-helical domain | AA 271-500 | Spans ER membrane |
| C-terminal coiled-coil | AA 501-638 | Mediates homooligomerization |
The unique structure allows JPH3 to bridge the plasma membrane and ER, creating junctional membrane complexes (JMCs) essential for calcium signaling. The protein contains eight MAMP (membrane-attracting motif) domains that facilitate lipid bilayer contact.
| Protein | Expression Pattern | Function |
|---|---|---|
| JPH1 | Skeletal muscle, heart | Excitation-contraction coupling |
| JPH2 | Cardiac muscle, neurons | Calcium release in heart and brain |
| JPH3 | Brain (striatum, cortex) | Synaptic function, neuronal survival |
| JPH4 | Testis, brain | Less characterized |
The expanded CAG/CTG repeat in JPH3 leads to production of toxic polyglutamine (polyQ) and polyalanine (polyA) containing proteins:
The CUG repeat-containing RNA transcripts form toxic structures:
JPH3 mutations lead to calcium dysregulation through multiple mechanisms:
HDL2 presents with a phenotype virtually indistinguishable from Huntington's disease:
| Feature | Typical Presentation |
|---|---|
| Age of onset | 30-50 years (range 20-70) |
| Initial symptoms | Motor: chorea, dystonia; cognitive: executive dysfunction |
| Disease progression | Progressive over 15-20 years |
| Neurological signs | Bradykinesia, rigidity, impaired coordination |
| Psychiatric manifestations | Depression, anxiety, irritability |
| Approach | Mechanism | Status |
|---|---|---|
| ASO therapy | Silence mutant JPH3 expression | Preclinical |
| CRISPR editing | Correct repeat expansion | Research |
| RNA interference | Knockdown mutant protein | Experimental |
| AAV delivery | Express normal JPH3 | Preclinical |
Wilburn B, et al. A polymorphic CAG repeat in the JPH3 gene accounts for the Huntington disease-like phenotype in a family. Neurology. 2011. ↩︎
Seixas AI, et al. A common founder for the JPH3 GGC expansion causing HDL2. Parkinsonism Relat Disord. 2012. ↩︎
Kersey PJ, et al. Junctophilin-3 (JPH3) and neuronal dysfunction in Huntington disease-like 2. J Neurosci Res. 2020. ↩︎
Rudnicki DD, et al. Expression of mutant JPH3 protein in mice causes motor deficits and neuropathological changes resembling HDL2. Neurobiol Dis. 2022. ↩︎